Emergent BioSolutions | Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.6B 10M 2025-09
Akebia Therapeutics USD 322M 180M 2025-06
ALKERMES USD 5.65B 696M 2026-02
Alnylam Pharmaceuticals USD 39.74B 12.8B 2026-02
Amarin USD 341M 4M 2025-09
ANI Pharmaceuticals USD 2.04B 630M 2025-09
BioMarin Pharmaceutical USD 10.4B 142M 2025-09
Coherus Biosciences USD 278M 184M 2025-06
Emergent BioSolutions USD 125M 51M 2023-12
Exact Sciences USD 10.36B 334M 2025-09
Exelixis USD 12.27B 523M 2026-02
Glaxosmithkline GBP 106.96B 20.08B 2026-02
Heron Therapeutics USD 145M 6M 2023-09
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
Ironwood Pharmaceuticals USD 213M 97M 2025-09
Lexicon Pharmaceuticals USD 267M 294M 2023-09
Lonza CHF 39.68B 980.61M 2025-06
Merck USD 300.37B 39.11B 2026-02
Moderna USD 16.5B 6.41B 2026-02
Myriad Genetics USD 494M 316M 2025-06
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 13.68B 465M 2026-02
Pacira USD 1.16B 51M 2025-09
Pfizer USD 152.89B 11.32B 2026-02
PTC Therapeutics USD 4.88B 1B 2025-09
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.02B 336M 2025-09
United Therapeutics USD 18.96B 6B 2025-09
Vanda Pharmaceuticals USD 243M 136M 2023-12
Xoma USD 162M 55M 2023-09


Emergent BioSolutions Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.